Jincheng Pharm: Mirabegron has obtained approval for the listing application of chemical raw materials
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, Jincheng Pharm announced that its wholly-owned subsidiary Beijing Jincheng Tail Pharmaceutical Co., Ltd. recently received the "Approval Notice for the Listing Application of Chemical Raw Materials" issued by the National Medical Products Administration. The name of the chemical raw material is: Mirabegron. Mirabegron is a selective β-3 adrenergic receptor agonist, primarily used for the treatment of overactive bladder (OAB), including symptoms such as urinary incontinence, urgency, and frequency
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments